×
验证码:
换一张
Forgotten Password?
Stay signed in
China Science and Technology Network Pass Registration
×
China Science and Technology Network Pass Registration
Log In
Chinese
|
English
中国科学院合肥物质科学研究院机构知识库
Knowledge Management System of Hefei Institute of Physical Science,CAS
Log In
Register
ALL
ORCID
Title
Creator
Subject Area
Keyword
Document Type
Source Publication
Indexed By
Publisher
Date Issued
Date Accessioned
Funding Project
MOST Discipline Catalogue
Study Hall
Image search
Paste the image URL
Home
Collections
Authors
DocType
Subjects
K-Map
News
Search in the results
Collection
Chinese A... [36]
合肥创新院 [2]
医学 [1]
Authors
Wang AoLi [47]
Liu QingS... [45]
Wang WenC... [40]
Hu Chen [31]
Wu Hong [29]
Qi ZiPing [21]
More...
Date Issued
2022 [2]
2021 [3]
2020 [5]
2019 [3]
2018 [7]
2017 [17]
More...
Language
英语 [44]
Source Publication
JOURNAL O... [16]
EUROPEAN J... [8]
ONCOTARGET [6]
ACTA PHARM... [3]
SIGNAL TRA... [2]
ACS Chem. ... [1]
More...
Funding Project
Frontier ... [11]
National ... [11]
CASHIPS Di... [8]
National N... [8]
China Post... [7]
National N... [7]
More...
Funding Organization
National ... [17]
Chinese A... [15]
Frontier ... [13]
National ... [13]
Natural S... [13]
CAS/SAFEA... [11]
More...
Indexed By
SCI [45]
Abstract
Document Type
Journal a... [46]
Thesis [1]
×
Knowledge Map
HFCAS OpenIR
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
QQ
Weibo
Feedback
Browse/Search Results:
1-10 of 47
Help
Show only claimed items
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Title Ascending
Title Descending
Submit date Ascending
Submit date Descending
Author Ascending
Author Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
Authors:
Cao, Jiang-yan
;
Qi, Shuang
;
Wu, Hong
;
Wang, Ao-li
;
Liu, Qing-wang
;
Li, Xi-xiang
;
Wang, Bei-lei
;
Ge, Juan
;
Zou, Feng-ming
;
Chen, Cheng
;
Wang, Jun-jie
;
Hu, Chen
;
Liu, Jing
;
Wang, Wen-chao
;
Liu, Qing-song
Favorite
  |  
View/Download:24/0
  |  
Submit date:2022/03/28
HER2
breast cancers
gastric cancers
irreversible inhibitor
drug resistance
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2
期刊论文
LEUKEMIA, 2022
Authors:
Yang, Jing
;
Weisberg, Ellen L.
;
Qi, Shuang
;
Ni, Wei
;
Mei, Husheng
;
Wang, Zuowei
;
Meng, Chengcheng
;
Zhang, Shengzhe
;
Hou, Mingqi
;
Qi, Ziping
;
Wang, Aoli
;
Jiang, Yunyun
;
Jiang, Zongru
;
Huang, Tao
;
Liu, Qingwang
;
Magin, Robert S.
;
Doherty, Laura
;
Wang, Wenchao
;
Liu, Jing
;
Buhrlage, Sara J.
;
Liu, Qingsong
;
Griffin, James D.
Favorite
  |  
View/Download:25/0
  |  
Submit date:2022/02/14
Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
期刊论文
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 卷号: 6
Authors:
Hu, Chen
;
Zou, Fengming
;
Wang, Aoli
;
Miao, Weili
;
Liang, Qianmao
;
Weisberg, Ellen L.
;
Wang, Yinsheng
;
Liu, Jing
;
Wang, Wenchao
;
Liu, Qingsong
Favorite
  |  
View/Download:5/0
  |  
Submit date:2021/11/01
Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML)
期刊论文
EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 卷号: 897
Authors:
Lu, Tingting
;
Cao, Jiangyan
;
Zou, Fengming
;
Li, Xixiang
;
Wang, Aoli
;
Wang, Wenliang
;
Liang, Huamin
;
Liu, Qingwang
;
Hu, Chen
;
Chen, Cheng
;
Hu, Zhenquan
;
Wang, Wenchao
;
Li, Lili
;
Ge, Jian
;
Shen, Yang
;
Ren, Tao
;
Liu, Jing
;
Xia, Ruixiang
;
Liu, Qingsong
Favorite
  |  
View/Download:11/0
  |  
Submit date:2021/04/26
BCR-ABL
ABL mutants
Chronic myeloid leukemia
Kinase inhibitor
Imatinib resistance
Selectively targeting FLT3-ITD mutants over FLT3-wt by a novel inhibitor for acute myeloid leukemia
期刊论文
HAEMATOLOGICA, 2021, 卷号: 106
Authors:
Wang, Aoli
;
Hu, Chen
;
Chen, Cheng
;
Liang, Xiaofei
;
Wang, Beilei
;
Zou, Fengming
;
Yu, Kailin
;
Li, Feng
;
Liu, Qingwang
;
Qi, Ziping
;
Wang, Junjie
;
Wang, Wenliang
;
Wang, Li
;
Weisberg, Ellen L.
;
Wang, Wenchao
;
Li, Lili
;
Ge, Jian
;
Xia, Ruixiang
;
Liu, Jing
;
Liu, Qingsong
Favorite
  |  
View/Download:9/0
  |  
Submit date:2021/04/26
Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma
期刊论文
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 卷号: 5
Authors:
Liu, Juan
;
Liang, Qianmao
;
Wang, Aoli
;
Zou, Fengming
;
Qi, Ziping
;
Yu, Kailin
;
Liu, Qingwang
;
Chen, Cheng
;
Liu, Jing
;
Liu, Qingsong
Favorite
  |  
View/Download:9/0
  |  
Submit date:2020/11/30
Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia
期刊论文
EXPERIMENTAL CELL RESEARCH, 2020, 卷号: 393
Authors:
Chen, Cheng
;
Wang, Li
;
Li, Lili
;
Wang, Aoli
;
Huang, Tao
;
Hu, Jie
;
Zhao, Ming
;
Liu, Feiyang
;
Qi, Shuang
;
Hu, Chen
;
Wang, Wenliang
;
Liu, Jing
;
Ge, Jian
;
Xia, Ruixiang
;
Wang, Wenchao
;
Liu, Qingsong
Favorite
  |  
View/Download:2/0
  |  
Submit date:2020/11/26
Acute myeloid leukemia (AML)
Drug response
Gene mutations
Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020
Authors:
Wang, Wen-liang
;
Jiang, Zong-ru
;
Hu, Chen
;
Chen, Cheng
;
Hu, Zhen-quan
;
Wang, Ao-li
;
Wang, Li
;
Liu, Jing
;
Wang, Wen-chao
;
Liu, Qing-song
Favorite
  |  
View/Download:20/0
  |  
Submit date:2020/11/26
PGK1
NG52
kinase inhibitor
Warburg effect
glioma
Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020
Authors:
Chen, Cheng
;
Cheng, Chuan-dong
;
Wu, Hong
;
Wang, Zuo-wei
;
Wang, Li
;
Jiang, Zong-ru
;
Wang, Ao-li
;
Hu, Chen
;
Dong, Yong-fei
;
Niu, Wan-xiang
;
Qi, Shuang
;
Qi, Zi-ping
;
Liu, Jing
;
Wang, Wen-chao
;
Niu, Chao-shi
;
Liu, Qing-song
View
  |  
Adobe PDF(3476Kb)
  |  
Favorite
  |  
View/Download:22/5
  |  
Submit date:2020/11/26
glioblastoma
osimertinib
temozolamide
MAPK-signaling pathway
MNK
eukaryotic translation initiation factor 4E
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
期刊论文
ACTA PHARMACEUTICA SINICA B, 2020, 卷号: 10
Authors:
Jiang, Zongru
;
Wang, Li
;
Liu, Xuesong
;
Chen, Cheng
;
Wang, Beilei
;
Wang, Wenliang
;
Hu, Chen
;
Yu, Kailin
;
Qi, Ziping
;
Liu, Qingwang
;
Wang, Aoli
;
Liu, Jing
;
Hong, Guangchen
;
Wang, Wenchao
;
Liu, Qingsong
Favorite
  |  
View/Download:9/0
  |  
Submit date:2020/11/26
Cancer
VEGFR2 kinase
Kinase inhibitor
Angiogenesis
Inhibitor selectivity